Oncology Research

Papers
(The median citation count of Oncology Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Galectins dysregulation: A way for cancer cells to invade and pervade36
Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities29
Long Noncoding RNA LAMTOR5-AS1 Interference Affects MicroRNA-506-3p/E2F6-Mediated Behavior of Non-Small Cell Lung Cancer Cells26
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP125
Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer24
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations22
lncCRLA Enhanced Chemoresistance in Lung Adenocarcinoma That Underwent EpithelialMesenchymal Transition21
Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma21
Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany21
Long noncoding RNA TFAP2A AS1 exerts promotive effects in non small cell lung cancer progression via controlling the microRNA 548a 3p/CDK4 axis20
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway19
System analysis based on the T cell exhaustion‑related genes identifies CD38 as a novel therapy target for ovarian cancer19
Prognostic-related genes for pancreatic cancer typing and immunotherapy response prediction based on single-cell sequencing data and bulk sequencing data18
Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis17
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells17
Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms16
uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells15
The role of LIN28B in tumor progression and metastasis in solid tumor entities14
Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas14
Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer14
Identification of lncRNAs associated with the progression of acute lymphoblastic leukemia using a competing endogenous RNAs network13
MicroRNA-296 Targets Specificity Protein 1 to Suppress Cell Proliferation and Invasion in Cervical Cancer [Oncology Research 26(5) (2018) 775783]12
Is autophagy induction by PARP inhibitors a target for therapeutic benefit?12
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials11
Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma11
YWHAH activates the HMGA1/PI3K/AKT/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells11
Retraction notice to High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells [Oncology Research 27(9) (2019) 102511
mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance10
Erratum: Inhibition of Beclin-1-Mediated Autophagy by MicroRNA-17-5p Enhanced the Radiosensitivity of Glioma Cells10
Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer10
Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study10
Deoxynortryptoquivaline: A unique antiprostate cancer agent10
The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells10
Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells10
Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer10
Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study9
A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker9
Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma9
Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways9
Progress in research on tumor microenvironment-based spatial omics technologies8
COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging8
MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma8
Thioredoxin domain-containing protein 9 protects cells against UV-B-provoked apoptosis via NF-κB/p65 activation in cutaneous squamous cell carcinoma8
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer8
The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment8
The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models8
Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma8
Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma7
Retraction notice to Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma [Oncology Research 26(3) (2018) 335343]7
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Gu閞in in patients with non-muscle invasive bladder carcinoma: A retrospective study7
Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis7
Erratum7
The zinc figure protein ZNF575 impairs colorectal cancer growth via promoting p53 transcription7
Retraction notice to Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the -Catenin Pathway [Oncology Research 25(8) (2017) 1377
Erratum6
The SMAD2/miR-4256/HDAC5/p16INK4a signaling axis contributes to gastric cancer progression6
Erratum: MicroRNA-133a Inhibits Proliferation of Gastric Cancer Cells by Downregulating ERBB2 Expression6
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer6
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape6
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission6
Identification of microbial metabolites that accelerate the ubiquitin-dependent degradation of c-Myc6
Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer6
()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes6
Tumor neoantigens: Novel strategies for application of cancer immunotherapy6
circRNAs in drug resistance of breast cancer6
Retraction notice to MicroRNA-204 Inhibits the Growth and Motility of Colorectal Cancer Cells by Downregulation of CXCL8 [Oncology Research 26(8) (2018) 12951305]6
A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab6
Erratum6
LSM12 facilitates the progression of colorectal cancer by activating the WNT/CTNNB1 signaling pathway6
Retraction notice to miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein [Oncology Research 26(7) (2018) 11131121]6
Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway6
0.026541948318481